Our experience with a new antitussive agent
Ciliberto, R.; Mazzaglia, E.
Minerva Pediatrica 27(28): 1551-1554
1975
ISSN/ISBN: 0026-4946 PMID: 1101023 Document Number: 85901
Document emailed within 1 workday
Related Documents
Wójcicki, J.; Samochowiec, L.; Szwed, G.; Sawiński, J. 1975: The use of Duopect as expectorant--antitussive agent Archivum Immunologiae et Therapiae Experimentalis 23(1): 135-142Christie, G.J.; Strom, P.W.; Rourke, J.E. 1980: Butorphanol tartrate: a new antitussive agent for use in dogs Veterinary Medicine-Small Animal Clinician 75(10): 1559-1562
Engelhorn, R.; Trieb, G.; Weller, E. 1973: Effect of a new antitussive and respiration-stimulating agent on the respiratory e -neurons in the medulla oblongata of the cat Arzneimittel-Forschung 23(Suppl 2a): 305-301
Taddei, M. 1971: Clinical trial of a delayed-action antitussive agent (Sinecod depot Hommel HH 10002) Schweizerische Rundschau für Medizin Praxis 60(17): 545-549
Kobayashi, S.; Hasegawa, K.; Mori, M.; Takagi, H. 1970: Pharmacological studies on a new specifically potent antitussive agent, 14-hydroxydihydro-6 beta-thebainol-4-methylether (oxymethebanol) Arzneimittel-Forschung 20(1): 43-46
Kozák, P.; Stárek, A.; Hes, I.; Spacek, R. 1985: Propafenone--a new antiarrhythmic agent. Clinical experience Casopis Lekaru Ceskych 124(13): 407-410
Ser, I. 1971: Clinical experience with glibenclamide, a new hypoglycemic agent Harefuah 81(8): 364-368
Davidoff, S.M. 1970: Experience with the antifibrinolytic agent Pamba in maxillofacial surgery Deutsche Stomatologie 20(5): 391-393
Fellner, R.; Simon, A. 1973: Clinical experience with a new vasotherapeutic agent in diseases of the fundus Klinische Monatsblatter für Augenheilkunde 162(6): 811-817
Rodríguez-Miñón, J.L.; Herrera Pombo, J.L.; Marrón, J.A. 1971: Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent) Revista Clinica Espanola 123(5): 439-442
Haspels, A.A. 1983: Clinical experience with a low-dose contraceptive agent. European studies Journal of Reproductive Medicine 28(1 Suppl): 71-76
Rolly, G.; Versichelen, L.; Herregods, L. 1985: Cumulative experience with propofol ('Diprivan') as an agent for the induction and maintenance of anaesthesia Postgraduate Medical Journal 61(Suppl 3): 96-100
Belorusov, O.S.; Goriaĭnov, V.A.; Egorova, I.A. 1986: Experience using an immunosuppressive agent sandimmun (cyclosporin A) in kidney transplantation in the clinic Khirurgiia 3: 72-76
Krcméry, V.; Horníková, M.; Koza, I.; Spanik, S.; Sufliarsky, J. 1990: Initial experience with fluconazole, a new triazole antimycotic agent, in oncology patients Casopis Lekaru Ceskych 129(22): 696-697
Steinke, L.; Kiskery, L. 1977: Experience with adalat, a coronary therapeutic agent in medical practice (authors transl) Schweizerische Rundschau für Medizin Praxis 66(11): 340-343
Varma, Y.S.; Sharma, P.L. 1971: Clinical experience with pancuronium bromide (NA97): a new steroid neuromuscular blocking agent Indian Journal of Medical Research 59(1): 69-75
Schöffski, P.; Weihkopf, T.; Ganser, A. 1998: Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel Anticancer Research 18(6b): 4751-4756
Wesch, G.; Petermann, C.; Linder, M.M. 1983: Drug therapy of peritonitis. 6-year experience with the chemotherapeutic agent and anti-endotoxin taurolin Fortschritte der Medizin 101(12): 545-550
Hanne, H.; Schröder, F. 1980: Clinical experience with the treatment of extraction wounds with a specific, resorbable, local hemostatic agent Zwr 89(12): 51
Balant, L.; Gorgia, A.; Marmy, A.; Tschopp, J.M. 1980: Clearance concept applied to pharmacokinetics: 2. Experience with tolamolol (beta-blocking agent) in renal insufficiency Nephrologie 1(4): 177-182